Clazakizumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Clazakizumab ?
Monoclonal antibody
Type Whole antibody
Source Humanized
Target IL6
Clinical data
Legal status
?
Identifiers
CAS number 1236278-28-6
ATC code None
Chemical data
Formula C6426H9972N1724O2032S42 
Mol. mass 145.2 kDa

Clazakizumab is a humanized monoclonal antibody designed for the treatment of rheumatoid arthritis.[1]

Clazakizumab was developed by Alder Biopharmaceuticals and Bristol-Myers Squibb.

References[edit]

  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Clazakizumab, American Medical Association.